MINERVA NEUROSCIENCE

NERV
Delayed Nasdaq - 12:57 2022-11-29 pm EST
3.280 USD -1.20%

Minerva Neurosciences Shares Leap 72% After Point72 Stake Disclosed

08/24/2022 | 03:59pm

By Stephen Nakrosis


Shares of Minerva Neurosciences Inc. soared nearly 73% to $7.81 per share on Wednesday.

After the bell Tuesday, billionaire hedge fund manager Steven Cohen's Point72 Asset Management L.P. disclosed that it has an 8.8% stake in the company.

On Monday, the Minerva's stock closed with a 47.83% gain after it submitted a new drug application with the U.S. Food and Drug Administration for roluperidone as a treatment for patients with schizophrenia.


Write to Stephen Nakrosis at stephen.nakrosis@wsj.com


(END) Dow Jones Newswires

08-24-22 1558ET

Copier lien
All news about MINERVA NEUROSCIENCES, INC.
11/11
11/10
11/09
11/09
11/09